Proteomics and Metabolomics Resources to Fuel Cancer Research
Official title: Advancing Cancer Research through Comprehensive Proteomics and Metabolomics Analyses
Funded at Wistar Institute · NIH-11411317 · Data updated 2026-11-12
A shared proteomics and metabolomics facility at leading cancer centers provides advanced analyses to support cancer research and other biomedical studies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wistar Institute NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | September 20, 2017 |
| Project end | August 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $237,136 |
| NIH project number | 5R50CA221838-10 |
| Project ID | NIH-11411317 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are individuals with cancer whose study involves molecular profiling, biomarker discovery, or therapeutic development that requires advanced proteomics/metabolomics data.
✕Less likely to help
Patients not involved in molecular profiling or whose research does not rely on advanced omics analyses may not directly benefit.
What this research studies
This grant funds a central facility that offers cutting-edge proteomics and metabolomics tests to cancer centers and other researchers. The Managing Director helps design experiments, analyzes data, and interprets results to ensure high-quality, up-to-date methods. The goal is to enable researchers to uncover molecular changes in tumors, body fluids, and cells that could lead to better understanding and treatment of cancer. Researchers from participating centers as well as other institutions can access these services to advance their projects.
Why it matters
Potential benefit: Patients may benefit indirectly through faster discovery of cancer biomarkers and therapies enabled by advanced proteomics/metabolomics analyses.
How similar studies have gone: Other centers have successfully used shared omics resources to accelerate cancer research and biomarker discovery.
Where this research is happening
-
Wistar Institute
Philadelphia, United States Active
Researchers
- Principal investigator: Tang, Hsin-Yao — Wistar Institute
- Study coordinator: Tang, Hsin-Yao
Related research
Other NIH-funded projects on the same topics.
-
Newborn screening: using gene and metabolite data to refine true vs false positives
A study using genetic and metabolomic data from newborn blood spots to better distinguish real metabolic disorders from false alarms.
-
IDEAL: How early-life immune development shapes vaccine responses and asthma risk
A child-focused project that looks at how the developing immune system in early life affects vaccine responses, respiratory infections, and asthma.
-
Integrative metabolomics to improve sarcoidosis diagnosis and prognosis
A research project from UCLA aims to find blood-based biomarkers that help diagnose sarcoidosis earlier and predict how it will progress, especially in African American women.
-
Metabolomics clues to how ultra-processed foods affect risk of type 2 diabetes
A scientist-led study will look at how eating different ultra-processed foods may change diabetes risk by using a controlled feeding trial and big population data, focusing on adults.
-
Longitudinal metabolomics in infants with food allergies
A study in infants aims to understand how gut metabolites relate to the development of food allergies, including IgE-mediated and non-IgE cases.
-
Biospecimen, Metabolomics, and Pathology Core for Endometrial Cancer Research
A national, multi-institutional resource collects and analyzes tissue, blood, and metabolites from endometrial cancer patients to support multiple research projects.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.